Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People

Resource: Additional mRNA COVID-19 Vaccines for Moderately to Severely Immunocompromised People

In this webinar, presenters discuss the data on COVID-19 vaccines in immunocompromised people, the role of additional doses of mRNA COVID-19 vaccines, patients who should be considered to receive these additional COVID-19 vaccine doses, results from the August 13, 2021, Advisory Committee on Immunization Practices (ACIP) meeting, and Centers for Disease Control and Prevention's (CDC) guidance on additional COVID-19 doses in immunocompromised people.

Source: CDC
Topic(s): Vaccination; Patient-Centered Care
Audience(s): Clinical Leaders, Clinicians
Format: Video
Length of Video: 1 hour
Publication Date: August 17, 2021